Clinically Evident Portal Hypertension: An Operational Research Definition for Future Investigations in the Pediatric Population

Childhood Liver Disease Research Network (ChiLDReN)

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Portal hypertension (PHT) is a major cause of morbidity and mortality in pediatric liver diseases. Thus, research into causes and disease modifiers in PHT in these conditions is vitally important. PHT is rarely directly or indirectly measured in the assessment of children with chronic liver disease. A straightforward, reproducible definition of PHT could be invaluable for consistently identifying patients with PHT and for grouping these patients according to their risk of complications from their disease. We propose the term Clinically Evident Portal Hypertension (CEPH) to denote clinical findings that demonstrate evidence of elevated portal pressure. When CEPH criteria are met, PHT is highly likely to be present, although it is likely that PHT exists for variable periods of time before meeting CEPH criteria. Use of this research definition of CEPH will allow for consistent identification of these patients by clinicians in nearly any clinical setting and serve as a clinical milepost that may dictate future prognosis in pediatric patients with cirrhosis.

Original languageEnglish (US)
Pages (from-to)763-767
Number of pages5
JournalJournal of pediatric gastroenterology and nutrition
Volume68
Issue number6
DOIs
StatePublished - Jun 1 2019

Fingerprint

Portal Hypertension
Pediatrics
Research
Population
Liver Diseases
Portal Pressure
Fibrosis
Chronic Disease
Morbidity

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Gastroenterology

Cite this

@article{65fe4a648f354aba8ce8f194550466c1,
title = "Clinically Evident Portal Hypertension: An Operational Research Definition for Future Investigations in the Pediatric Population",
abstract = "Portal hypertension (PHT) is a major cause of morbidity and mortality in pediatric liver diseases. Thus, research into causes and disease modifiers in PHT in these conditions is vitally important. PHT is rarely directly or indirectly measured in the assessment of children with chronic liver disease. A straightforward, reproducible definition of PHT could be invaluable for consistently identifying patients with PHT and for grouping these patients according to their risk of complications from their disease. We propose the term Clinically Evident Portal Hypertension (CEPH) to denote clinical findings that demonstrate evidence of elevated portal pressure. When CEPH criteria are met, PHT is highly likely to be present, although it is likely that PHT exists for variable periods of time before meeting CEPH criteria. Use of this research definition of CEPH will allow for consistent identification of these patients by clinicians in nearly any clinical setting and serve as a clinical milepost that may dictate future prognosis in pediatric patients with cirrhosis.",
author = "{Childhood Liver Disease Research Network (ChiLDReN)} and Bass, {Lee M} and Shneider, {Benjamin L.} and Lisa Henn and Goodrich, {Nathan P.} and Magee, {John C.}",
year = "2019",
month = "6",
day = "1",
doi = "10.1097/MPG.0000000000002333",
language = "English (US)",
volume = "68",
pages = "763--767",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

Clinically Evident Portal Hypertension : An Operational Research Definition for Future Investigations in the Pediatric Population. / Childhood Liver Disease Research Network (ChiLDReN).

In: Journal of pediatric gastroenterology and nutrition, Vol. 68, No. 6, 01.06.2019, p. 763-767.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinically Evident Portal Hypertension

T2 - An Operational Research Definition for Future Investigations in the Pediatric Population

AU - Childhood Liver Disease Research Network (ChiLDReN)

AU - Bass, Lee M

AU - Shneider, Benjamin L.

AU - Henn, Lisa

AU - Goodrich, Nathan P.

AU - Magee, John C.

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Portal hypertension (PHT) is a major cause of morbidity and mortality in pediatric liver diseases. Thus, research into causes and disease modifiers in PHT in these conditions is vitally important. PHT is rarely directly or indirectly measured in the assessment of children with chronic liver disease. A straightforward, reproducible definition of PHT could be invaluable for consistently identifying patients with PHT and for grouping these patients according to their risk of complications from their disease. We propose the term Clinically Evident Portal Hypertension (CEPH) to denote clinical findings that demonstrate evidence of elevated portal pressure. When CEPH criteria are met, PHT is highly likely to be present, although it is likely that PHT exists for variable periods of time before meeting CEPH criteria. Use of this research definition of CEPH will allow for consistent identification of these patients by clinicians in nearly any clinical setting and serve as a clinical milepost that may dictate future prognosis in pediatric patients with cirrhosis.

AB - Portal hypertension (PHT) is a major cause of morbidity and mortality in pediatric liver diseases. Thus, research into causes and disease modifiers in PHT in these conditions is vitally important. PHT is rarely directly or indirectly measured in the assessment of children with chronic liver disease. A straightforward, reproducible definition of PHT could be invaluable for consistently identifying patients with PHT and for grouping these patients according to their risk of complications from their disease. We propose the term Clinically Evident Portal Hypertension (CEPH) to denote clinical findings that demonstrate evidence of elevated portal pressure. When CEPH criteria are met, PHT is highly likely to be present, although it is likely that PHT exists for variable periods of time before meeting CEPH criteria. Use of this research definition of CEPH will allow for consistent identification of these patients by clinicians in nearly any clinical setting and serve as a clinical milepost that may dictate future prognosis in pediatric patients with cirrhosis.

UR - http://www.scopus.com/inward/record.url?scp=85066918548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066918548&partnerID=8YFLogxK

U2 - 10.1097/MPG.0000000000002333

DO - 10.1097/MPG.0000000000002333

M3 - Article

C2 - 30908382

AN - SCOPUS:85066918548

VL - 68

SP - 763

EP - 767

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 6

ER -